1. Yang XH#, Li MH#, Jiang J#, Hu XW, Qing Y, Sun LY, Yang TQ, Wang DD, Cui GP, Gao Y, Zhang J, Li XW, Shen YH, Qin SY, Wan CL*. Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia. Ebiomedicine. 2021;64.

2. Li MH#, Yang XH#, Sun LY, Qing Y, Hu XW, Jiang J, Wang DD, Cui GP, Gao Y, Zhang E, Zhang J, Yang Y*, Wan CL*. Decreased serum apolipoprotein A4 as a potential peripheral biomarker for patients with schizophrenia. J Psychiatr Res. 2021;137:14-21.

3. Wang DD#, Hu XW#, Jiang J, Sun LY, Qing Y, Yang XH, Gao Y, Cui GP, Li MH, Wang PK, Zhang J, Zhuang Y, Li ZZ, Li J, Guan LL, Zhang TH, Wang JJ, Ji F*, Wan CL*. Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker. Schizophr Res. 2021;230:53-60.

4. Cui GP#, Qing Y#, Hu XW, Wang PK, Sun LY, Yang XH, Jiang J, Zhang J, Wang H, Feng L, Shen YH, Qin SY*, Wan CL*. Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia? Antioxid Redox Sign. 2020;33:679-688.

5. Xu CY, Yang XH, Sun LY, Yang TQ, Cai CQ, Wang P, Jiang J, Qing Y, Hu XW, Wang DD, Wang PK, Cui GP, Zhang J, Li Y, Feng J, Liu CX, Wan CL*. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia. Psychiat Res. 2019;273:782-787.

6. Jiang J#, Peng C#, Sun LY, Li J, Qing Y, Hu XW, Yang XH, Li Y, Xu CY, Zhang J, Min J, Li XW, Qin SY, Lin M, Tan LW, Wan CL*. Leukocyte Proteomic Profiling in First-Episode Schizophrenia Patients: Does Oxidative Stress Play Central Roles in the Pathophysiology Network of Schizophrenia? Antioxid Redox Sign. 2019;31:579-588.

7. Sun LY, Yang XH, Jiang J, Hu XW, Qing Y, Wang DD, Yang TQ, Yang C, Zhang J, Yang P, Wang P, Cai CQ, Wang JJ, He L, Wan CL*. Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population. Schizophrenia Bull. 2018;44:896-907.

8. Qing Y#, Sun LY#, Yang C, Jiang J, Yang XH, Hu XW, Cui DH, Xu YF, He L, Han DM, Wan CL*. Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia. Sci Rep-Uk. 2016;6.

9. Sun LY#, Qing Y#, Yang XH, Yang C, Jiang J, Hu XW, Ding JY, He L, Tan LW*, Wan CL*. Gene Expression Profiling of the xMHC Region Reveals 9 Candidate Genes in Schizophrenia. J Clin Psychiat. 2016;77:E597-U575.

10. Qing Y, Yang JL, Wan CL*. Increased serum fibroblast growth factor 21 levels in patients with schizophrenia. Aust Nz J Psychiat. 2015;49:849-850.

1. Yang XH#, Li MH#, Jiang J#, Hu XW, Qing Y, Sun LY, Yang TQ, Wang DD, Cui GP, Gao Y, Zhang J, Li XW, Shen YH, Qin SY, Wan CL*. Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia. Ebiomedicine. 2021;64.

2. Li MH#, Yang XH#, Sun LY, Qing Y, Hu XW, Jiang J, Wang DD, Cui GP, Gao Y, Zhang E, Zhang J, Yang Y*, Wan CL*. Decreased serum apolipoprotein A4 as a potential peripheral biomarker for patients with schizophrenia. J Psychiatr Res. 2021;137:14-21.

3. Wang DD#, Hu XW#, Jiang J, Sun LY, Qing Y, Yang XH, Gao Y, Cui GP, Li MH, Wang PK, Zhang J, Zhuang Y, Li ZZ, Li J, Guan LL, Zhang TH, Wang JJ, Ji F*, Wan CL*. Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker. Schizophr Res. 2021;230:53-60.

4. Cui GP#, Qing Y#, Hu XW, Wang PK, Sun LY, Yang XH, Jiang J, Zhang J, Wang H, Feng L, Shen YH, Qin SY*, Wan CL*. Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia? Antioxid Redox Sign. 2020;33:679-688.

5. Xu CY, Yang XH, Sun LY, Yang TQ, Cai CQ, Wang P, Jiang J, Qing Y, Hu XW, Wang DD, Wang PK, Cui GP, Zhang J, Li Y, Feng J, Liu CX, Wan CL*. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia. Psychiat Res. 2019;273:782-787.

6. Jiang J#, Peng C#, Sun LY, Li J, Qing Y, Hu XW, Yang XH, Li Y, Xu CY, Zhang J, Min J, Li XW, Qin SY, Lin M, Tan LW, Wan CL*. Leukocyte Proteomic Profiling in First-Episode Schizophrenia Patients: Does Oxidative Stress Play Central Roles in the Pathophysiology Network of Schizophrenia? Antioxid Redox Sign. 2019;31:579-588.

7. Sun LY, Yang XH, Jiang J, Hu XW, Qing Y, Wang DD, Yang TQ, Yang C, Zhang J, Yang P, Wang P, Cai CQ, Wang JJ, He L, Wan CL*. Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population. Schizophrenia Bull. 2018;44:896-907.

8. Qing Y#, Sun LY#, Yang C, Jiang J, Yang XH, Hu XW, Cui DH, Xu YF, He L, Han DM, Wan CL*. Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia. Sci Rep-Uk. 2016;6.

9. Sun LY#, Qing Y#, Yang XH, Yang C, Jiang J, Hu XW, Ding JY, He L, Tan LW*, Wan CL*. Gene Expression Profiling of the xMHC Region Reveals 9 Candidate Genes in Schizophrenia. J Clin Psychiat. 2016;77:E597-U575.

10. Qing Y, Yang JL, Wan CL*. Increased serum fibroblast growth factor 21 levels in patients with schizophrenia. Aust Nz J Psychiat. 2015;49:849-850.